Awareness of Chronic Kidney Disease, Medication, and Laboratory Investigation among Nephrology and Urology Patients of Quetta, Pakistan

Jahanzaib Ahmed, Saira Azhar, Noman ul Haq, Sajjad Hussain, Anette Stájer, Edit Urbán, Márió Gajdács and Shazia Jamshed
Additional contact information
Jahanzaib Ahmed: College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan
Saira Azhar: College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan
Noman ul Haq: Faculty of Pharmacy and Health Sciences, University of Balochistan, Quetta 87300, Pakistan
Sajjad Hussain: College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan
Anette Stájer: Department of Periodontology, Faculty of Dentistry, University of Szeged, 6720 Szeged, Hungary
Edit Urbán: Department of Medical Microbiology and Immunology, University of Pécs Medical School, Szigeti út 12., 7624 Pécs, Hungary
Márió Gajdács: Department of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, 6720 Szeged, Hungary
Shazia Jamshed: Department of Clinical Pharmacy and Practice, Faculty of Pharmacy, Universiti Sultan Zainal Abidin, Kuala Terengganu 21300, Malaysia

IJERPH, 2022, vol. 19, issue 9, 1-15

Abstract: Patients’ awareness is critical in medical care, as it can serve as an input into the adjustment of interventions. The aim of study was to explore the level of awareness regarding chronic kidney disease (CKD), its medications, and laboratory investigations among nephrology and urology patients of Quetta. The cross-sectional study was used by adopting and culturally modifying a questionnaire. By convenient sampling technique, a total of 500 questionnaires were self-administered to inpatients, outpatients, and dialysis patients, and 468 responses (response rate 93.6%) were analyzed. Descriptive statistics, inferential statistics, and reliability analysis were performed on SPSS v25. A majority, 50.3% ( n = 235), was unaware of symptoms that will develop due to worsening of disease, while 56.2% ( n = 263) were unaware of what aggravates their kidney function. Almost half of the affected individuals, 47.4% ( n = 222), have no understanding about the long-term prognosis of the disease. The majority of the respondents, 51.5% ( n = 248), do not know about the names and usage of medications, and 62.4% ( n = 292) were unaware of the medicines that may impair kidney function; more than half, 66.7% ( n = 312), were unaware about the necessary laboratory investigations. A strong association between awareness and patient education level was found ( p < 0.001). Awareness regarding disease condition, medications, and laboratory investigations of CKD among nephrology and urology patients of Quetta was found out to be low, which needs immediate educational intervention.

Keywords: awareness; knowledge; CKD; nephrology; urology; laboratory; medications (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/9/5015/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/9/5015/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:9:p:5015-:d:798219

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().